Nascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic ...

Retrieved on: 2022-06-07 12:22:54

Tags for this article:

Click the tags to see associated articles and topics

Nascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic .... View article details on hiswai:

Excerpt

... "Nascent", or the "Company"), a clinical-stage biotechnology Company pioneering the development of monoclonal antibodies targeting treatment ...

Article found on: www.biospace.com